• What We Do
  • Who We Are
  • Simulations
  • Presentations & Research
  • Contact Us
  • White Paper
  • Disclaimer
  • Industry Sector
  • Global Region
  • ETF's and Futures
  • Major Funds - Holding
  • Tutorial
  • Best Risk Adjusted
  • Worst Risk Adjusted
  • Best Expected
  • Worst Expected
  • Sector Ranking
  • Dividend
  • REIT's
  • Leverage Risk
  • Convertible Bonds
  • Investment Grade
  • High Yield
  • ADR
  • Small Caps
Rational Investing
  • About Usarrow_drop_down
  • Coveragearrow_drop_down
  • Returnsarrow_drop_down
  • Productarrow_drop_down


Drugs - Generic

       Total Market Capitalization of All Firms $101,970 mm             
       Average Market Capitalization $16,995 mm       
       Average Market to Model Ratio Weighted by Log of Market Cap 0.7       
       Standard Deviation of MM Ratio 0.2       
       Average Beta 1.0       
       Average EV To Revenue 3.1       
       Average EV To EBITDAM 12.5       
       Average Price To Free Cash Flow 11.8       

TickerCompany NameMarket To ModelMarket Cap ($ mm)EV to RevenuePrice To FCFEV/EBITDAM% GrowthBetaAs Of
PBHPrestige Brands Holdings Inc.1.051,8453.611.312.220.8Mar 20
PRGOPerrigo Co.0.907,3792.017.113.0111.2Mar 20
AGNAllergan PLC0.8163,2725.215.817.931.2Mar 20
RDYDr Reddy Laboratories Ltd0.588,6063.218.014.5130.4Mar 20
MYLMylan N.V.0.508,1851.84.57.441.5Mar 20
TEVATeva Pharmaceutical Industries0.4012,6832.53.99.8-11.0Mar 20
Standard Value | About us | Contact us     Copyright © 2003-2020 Rational Investing LLC ® | All Rights Reserved